INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
WEARABLES
WEARABLES
Omar Rahman
Enable Injections
ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY
Omar Rahman, Beth Faiman and Lisa Gorski highlight the importance of a comfortable experience for both patients and healthcare providers when it comes to large-volume subcutaneous drug delivery.
WEARABLES
Dr Andrea Allmendinger
ten23 health
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
Andrea Allmendinger, Michael Adler, Carole Delauney and Hanns-Christian Mahler provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
EARLY INSIGHT
Dr Chaoyoung Lee
TxSphere
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.
EXPERT VIEW
Dave Beckstoffer
THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS
Dave Beckstoffer considers how involving customisation from the outset of an on-body injector development project can not only optimise the patient outcome but also streamline the development timescale for device engineers, with a particular focus on the drive system.
INDUSTRIALISATION
Lorenzo Vaccarella
Paragon Medical
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.
INDUSTRIALISATION
Ian Thompson
Ypsomed
YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES
Ian Thompson describes how Ypsomed has transformed the market for platform-based self-injection devices and extended the concept of platform products beyond the core device by developing working practices with strategic networking partners, helping pharma companies and patients to source safe, reliable and easy-to-use drug-device combination products.
EXPERT VIEW
Dave Beckstoffer
MATERIAL SELECTION & EFFICIENT DEVELOPMENT PROCESSES FOR WEARABLE INJECTOR DRIVE SYSTEMS
Dave Beckstoffer explains the importance of material selection in drive system development, the key attributes of materials towards a wearable and auto-delivery device, and discusses the need to achieve industrialisation based on material selection and relevant manufacturing processes.
CONNECTIVITY
Damien McKeon
Aptar Digital Health
BRINGING DIGITAL HEALTH AND DRUG DELIVERY TOGETHER TO SUPPORT SUBCUTANEOUS INJECTION IN ONCOLOGY
Damien McKeon and Sueyoung Yoon discuss the trends driving interest in subcutaneous administration, the barriers to overcome and the characteristics of a patient-centric solution.
INJECTION
Lucas Foerster
Sartorius
CHALLENGES IN TESTING THE ACCURACY OF INFUSION PUMP DOSES
Lucas Foerster and Dieter Peissig explore the critical factors in choosing the right balance for infusion pump performance validation and discuss potential sources of error.
INJECTION
Dr Michael Adler
ten23 health
TRANSITIONING FROM VIAL TO SUBCUTANEOUS INJECTION DEVICES FOR BIOLOGICAL DRUG PRODUCTS
Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post-launch, especially when transferring from a vial format for intravenous infusion.
INTERVIEW
Reto Jost
Ypsomed
INTERVIEW: THE BENEFITS OF BEING AN EARLY ADOPTER OF SUSTAINABILITY PRINCIPLES
Reto Jost and Gabriel Kalbermatter talk exclusively with ONdrugDelivery's Guy Furness, discussing the progress Ypsomed has made in advancing its sustainability agenda, particularly the implementation of its ecodesign guideline, the benefits of being an early adopter of sustainability principles, how YpsoMate 5.5 mL has been designed from the ground up with sustainability in mind and where sustainability considerations currently fit into the wider pharma industry.
EXPERT VIEW
Su Osorio
SUSTAINABLE BY DESIGN: DEVELOPING PATIENT- AND PLANET-CENTRIC MEDICAL DEVICES
Su Osorio, Stephanie Mou and Charlie Dean, explore the delicate balance between patient and planet centricity and propose a user- and planet-centric approach for the development of sustainable medical devices.
EXPERT VIEW
Tom Oakley
Sanner Group
DRUG DELIVERY TRENDS FOR 2024
Tom Oakley and Kamaal de Silva consider how keeping abreast of the latest trends can help the industry predict and prepare for the future and, commenting from Springboard's privileged position at the centre of many of the drug delivery sector’s most exciting developments, discuss the top trends to look out for in 2024.
INJECTION
Peter Schmidt
ZwickRoell
FAST, STANDARD-COMPLIANT AND COST-EFFICIENT TESTING OF PREFILLED SYRINGES FOR OPTIMAL RESULTS
Peter Schmidt presents ZwickRoell’s solutions for testing autoinjectors and wearables to ensure a systematic increase in productivity in the testing lab.
WEARABLES
Omar Rahman
Enable Injections
BEYOND THE POINT: NAVIGATING THE IMPACT OF NEEDLES ON PAIN, ANXIETY AND THE PATIENT EXPERIENCE
Omar Rahman, Mehul Desai and Keith Candiotti discuss the role that needle size plays in the pain and anxiety patients experience during injections and how smaller, hidden needles (30G), such as those employed by Enable Injections’ enFuse large-volume injector, may minimise patient discomfort and maximise subcutaneous injection efficiency.
WEARABLES
Dr Hong-Jun Yeh
MicroMED Co Ltd
ADVANCING SUBCUTANEOUS DELIVERY OF BIOLOGICS: A NOVEL REUSABLE MEMS-ENABLED ACTUATOR
Hong-Jun Yeh, Jiunn-Ru Lai and Tsung-Chieh Cheng explore the challenges and opportunities related to the subcutaneous delivery of biotherapeutics. They also highlight a novel reusable MEMS-enabled pneumatic actuation system designed to overcome these challenges.
CONNECTIVITY
Pascal Dugand
Nemera
HOW TO NAVIGATE A COMPLEX CONNECTIVITY ENVIRONMENT
Pascal Dugand, Cécile Gross and Mark Tunkel consider the complexity of the landscape for connected devices and demonstrate how a balance can be achieved between patient needs, technology and the cost of integrating this technology into a device.
EXPERT VIEW
Paramesh Natarajan
HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN
Paramesh Natarajan, Shadi Bavar and Charlie Dean present the case for using screening lifecycle assessments to lead into more detailed targeted and comprehensive lifecycle assessments focused on the areas of greatest environmental impact, using a screening lifecycle assessment of a hypothetical body-worn injector as an example.
EXPERT VIEW
Tom Oakley
“A CHILD IS NOT A SMALL ADULT”: CHALLENGES AND SOLUTIONS IN DEVELOPING DRUG DELIVERY DEVICES FOR CHILDREN
Tom Oakley and Heather Jameson consider the main differences in developing therapies and drug delivery devices for children and babies when compared with adults.
WEARABLES
Christian Esser Wiesemann
Ypsomed
YPSODOSE – THE CLINIC-READY 10 ML PATCH INJECTOR
Christian Esser Wiesemann provides the latest insights into the prefilled and pre-assembled YpsoDose patch injector, which is now available for clinical trials.
WEARABLES
Dr Mehul Desai
Enable Injections
A NEW FRONTIER: SELF-ADMINISTRATION OF LYOPHILISED, LARGE-VOLUME SUBCUTANEOUS BIOLOGICS
Mehul Desai and Daniel Waites discuss the pros and cons of lyophilisation for biologic injectable drugs, and how Enable Injections’ enFuse device can provide an answer to the challenges of self-injection of large-volume and lyophilised biologics.
WEARABLES
Heiko Haller
ZwickRoell
PRODUCT SHOWCASE: COMPLETE SYSTEM FOR STANDARD-COMPLIANT TESTING OF WEARABLE INJECTORS
Specifically tailored to on-body delivery systems (OBDSs) / wearable injectors, ZwickRoell showcases its customised, comprehensive solution for performing functional tests in accordance with the ISO 11608-6 standard.
SUSTAINABILITY
Maike Wolf
Gerresheimer
SUSTAINABLE DESIGN OF A DRUG DELIVERY DEVICE FOR BIOPHARMACEUTICALS
Maike Wolf and Marie Stockton discuss how sustainability is a fundamental strategic priority for Gerresheimer. They also highlight how eco-design principles have been applied to the development of an on-body injector for subcutaneous delivery of biopharmaceuticals.
WEARABLES
Thomas Mayer
Sonceboz
COMPARISON OF MECHATRONIC VS MECHANICAL WEARABLE DRUG DELIVERY SYSTEMS
Thomas Mayer, Nicolas Bailo and Martin Liniger highlight some of the key challenges that mechanical and mechatronic drug delivery systems must overcome when delivering large volumes of biologics subcutaneously and explain the solutions that Sonceboz has considered during the development process of the company’s large-volume injector.
Prev
1
2
3
4
5
…
12
Next
Top
